6632 Organometallics, Vol. 26, No. 26, 2007
Vela et al.
for 1 h at room temperature. Pyridine (12.1 mL, 150 mmol) was
added, and the resulting pale yellow solution was stirred for 35
min. The mixture was concentrated to ca. 20 mL under vacuum,
and Et2O (100 mL) was added. A pale yellow precipitate formed
and was collected by filtration and purified twice by dissolution in
CH2Cl2 (20 mL) and precipitation with Et2O (100 mL). The final
product was dried under vacuum to give 6a as a white powder.
Figure 8. Numbering scheme used for NMR labeling.
1
Yield: 12.5g, 69%. H NMR (CD2Cl2): δ 8.75 (d, JHH ) 5, 2H,
(15 mL) was added dropwise. The dark solution was warmed to
room temperature and stirred for 1 h. The solvent was removed
under vacuum, and ether (20 mL) was added. The resulting
suspension was stirred for 10 min at room temperature and filtered
to afford a yellow solid. The solid was dried under vacuum, taken
up in CH2Cl2 (20 mL), filtered, concentrated under vacuum, and
cooled to -20 °C. Several crops of a bright yellow powder were
o-py), 7.94 (dd, JHH ) 6, JPH ) 5, 1H, H3-ArSO3), 7.87 (t, JHH
)
8, 1H, p-py), 7.70–7.52 (br, 4H, H4-ArOMe/H6-ArOMe), 7.50 (t,
JHH ) 7, 2H, m-py), 7.27 (d, JHH ) 8, 1H, H4-ArSO3), 7.11–6.97
(m, 5H, H6-ArSO3/H3-ArOMe/H5-ArOMe), 3.67 (s, 6H, OMe), 2.25
(s, 1H, CH3ArSO3), 0.23 (d, 3H, JPH ) 3, PdMe). 13C{1H} NMR
(CD2Cl2): δ 161.0 (s, C2-ArOMe), 150.7 (s, o-py), 146.3 (d, JPC
)
16, C2-ArSO3), 138.9 (d, JPC ) 8, C3-ArSO3), 138.6 (s, C6-ArSO3),
137.8 (br s, C4-ArOMe), 135.4 (s, p-py), 133.5 (s, m-py), 131.1 (s,
C4-ArSO3), 127.8 (d, JPC ) 8, C5-ArSO3), 127.5 (d, JPC ) 50, C1-
ArSO3), 125.4 (s, C5-ArOMe), 120.8 (d, JPC ) 12, C6-ArOMe),
116.7 (d, JPC ) 57, C1-ArOMe), 111.8 (s, C3-ArOMe), 55.6 (s,
OMe), 21.2 (s, CH3ArSO3), 0.27 (d, JPC ) 4, PdMe). 31P{1H} NMR
(CD2Cl2): δ 19.8 (s). ESI-MS (CH2Cl2/MeOH, 1:1 by volume,
positive ion scan, m/z): 616.0 (MH+).
1
obtained by filtration. Yield: 0.31 g (23%). Mp: 219 °C (dec). H
NMR (CD2Cl2): δ 8.47 (d, JHH ) 5, 2H, o-py), 7.86 (dd, JHH ) 8,
JPH ) 5, 1H, H3-ArSO3), 7.73 (m, 3H, p-py/H6-ArOMe), 7.58 (t,
JHH ) 7, 2H, m-py), 7.29 (t, JHH ) 6, 2H, H5-ArOMe), 7.27 (d,
JHH ) 8, 1H, H4-ArSO3), 7.15 (d, JPH ) 12, 1H, H6-ArSO3), 7.08
(t, JHH ) 7, 2H, H4-ArOMe), 7.01 (dd, JHH ) 8, JPH ) 4, 2H,
H3-ArOMe), 6.84 (t, JHH ) 7, 1H, p-CH2Ph), 6.73 (t, JHH ) 8, 2H,
m-CH2Ph), 6.40 (d, JHH ) 8, 2H, o-CH2Ph) 3.69 (s, 6H, ArOMe),
2.45 (d, JPH ) 5, 2H, CH2Ph), 2.25 (s, 3H, Me-ArSO3). 13C{1H}
NMR (CD2Cl2): δ 161.3 (s, C2-ArOMe), 151.0 (s, o-py), 146.4 (d,
JPC ) 15, C2-ArSO3), 138.9 (d, JPC ) 6, C3-ArSO3), 138.4 (m,
ipso-CH2Ph), 138.1 (s, C6-ArSO3), 135.6 (s, p-py), 133.9 (s, m-py),
131.2 (d, JPC ) 2, C5-ArSO3), 128.6 (s, o-CH2Ph), 128.3 (s,
m-CH2Ph), 128.0 (d, JPC ) 9, C6-ArOMe), 127.6 (s, C4-ArSO3),
125.3 (s, p-CH2Ph), 124.2 (s, C5-ArOMe), 121.2 (d, JPC ) 11, C4-
ArOMe), 116.2 (d, JPC ) 55, C1-ArOMe), 112.0 (d, JPC ) 4, C3-
ArOMe), 55.8 (s, OMe), 22.9 (s, CH2Ph), 21.5 (s, Me-ArSO3); the
C1-ArSO3 was not observed, probably due to overlap with signals
in the δ 124-128 region. 31P{1H} NMR (CD2Cl2): δ 20.7 (s). Anal.
Calcd for C33H32NO5PPdS: C, 57.27; H, 4.66; N, 2.02. Found: C,
57.41; H, 4.80; N, 2.04.
[PO-Et]Pd(Me)(py) (6b). A solution of [PO-Et]H (1.61 g, 3.90
mmol) and (TMEDA)PdMe2 (0.985 g, 3.90 mmol) in CH2Cl2 (40
mL) was cooled to -78 °C and stirred for 20 min. Pyridine (1.57
mL, 19.5 mmol) was added dropwise over 2 min. The mixture was
stirred at -78 °C for 30 min, warmed to room temperature, and
stirred for 45 min. A pale yellow solution formed. The volatiles
were removed under vacuum to afford a pale yellow solid. This
material was recrystallized from CH2Cl2/hexanes (1:1 by volume,
-30 °C, 4 days) to afford [PO-Et]Pd(Me)(py) as pale yellow
crystals, which were isolated by filtration, washed with hexanes,
and dried under vacuum. Yield: 0.980 g, 41%. 1H NMR (CD2Cl2):
δ 8.80 (m, 2H, H2-py), 8.05 (dd, JHH ) 8, JPH ) 5, 1H, H3-ArSO3),
7.88 (m, 1H, H4-py), 7.50 (m, 2H, H3-py), 7.4–7.2 all other aromatic
protons (broadened due to exchange), 6.85 (d, JPH ) 10, 1H, H6-
ArSO3), 3.22 (s, 2H, ArCH2CH3), 3.10 (s, 1H, ArCH2CH3), 2.77
(s, 1H, ArCH2CH3), 2.22 (s, 3H, CH3ArSO3), 1.58 (s, ArCH2CH3),
0.88 (s, ArCH2CH3), 0.40 (d, JPH ) 2, 3H, Pd-CH3). 13C{1H} NMR
(CD2Cl2): δ 150.7 (s, o-py), 148.5 (d, JPC ) 43, C1-ArEt), 147.2
(d, JPC ) 14, C2-ArSO3), 140.4 (d, JPC ) 8, C3-ArSO3), 138.8 (s,
C5-ArSO3), 136.3 (br, C6-ArEt), 135.2 (s, p-py), 134.1 (br s, C5-
ArEt), 132.3 (s, m-Py), 131.7 (d, JPC ) 43, C2-ArEt), 129.9 (br s,
C3-ArEt), 129.3 (d, JPC ) 9, C6-ArSO3), 126.8 (d, JPC ) 48, C1-
ArSO3), 126.4 (br s, C4-ArEt), 125.6 (s, C4-ArSO3), 29.0 (s,
ArCH2CH3), 28.0 (s, ArCH2CH3), 21.2 (s, CH3ArSO3), 15.6 (s,
ArCH2CH3), 13.9 (s, ArCH2CH3), 3.2 (s, Pd-CH3). 31P{1H} NMR
(CD2Cl2): δ 19.5 (s). ESI-MS (CH2Cl2/MeOH, 1:1 by volume,
positive ion scan, m/z): 612.0 (MH+). Anal. Calcd for
[PO-OMe]Pd(Me)(pyridazine) (5a). A suspension of [PdMe2
(pyridazine)]n (0.132 g, 0.610 mmol) in CH2Cl2 (15 mL) was cooled
to -78 °C, and a solution of [PO-OMe]H (0.254 g, 0.610 mmol)
in CH2Cl2 (15 mL) was added dropwise while the mixture was
stirred. The resulting bright yellow suspension was allowed to warm
to room temperature to afford a colorless solution. The solution
was stirred at room temperature for 1 h, concentrated to 4 mL, and
placed in a freezer at -20 °C. Several fractions of a microcrystalline
white solid were collected by filtration. Yield: 0.263 g (70%). Mp:
1
80 °C (dec). H NMR (CD2Cl2): δ 9.42 (br s, 2H, C4H4N2), 7.95
(dd, JHH ) 7.9, JPH ) 5, 1H, H3-ArSO3), 7.74 (br s, 2H, C4H4N2),
7.60 (br s, 2H, H6-ArOMe), 7.54 (t, JHH ) 8, 2H, H4-ArOMe),
7.28 (d, JHH ) 8, 1H, H4-ArSO3), 7.10 (d, JPH ) 12, 1H, H6-ArSO3),
7.03 (t, JHH ) 8, 2 H, H5-ArOMe), 6.97 (dd, JHH ) 8, JPH ) 5,
2H, H3-ArOMe), 3.66 (s, 6H, ArOMe), 2.26 (s, 3H, Me-ArSO3),
0.44 (d, JPH ) 2, 3H, Pd-Me). 13C{1H} NMR (CD2Cl2): δ 161.2
(d, JPC ) 2, C2-ArOMe), 153.5 (br s, C4H4N2), 146.4 (d, JPC ) 15,
C2-ArSO3), 139.1 (d, JPC ) 6, C6-ArSO3), 138.0 (br s, C5-ArSO3),
135.6 (d, JPC ) 2, C3-ArSO3), 133.7 (s, C5-ArOMe), 131.2 (s, C4-
ArSO3), 129.7 (br s, C4H4N2), 128.1 (d, JPC ) 9, C6-ArOMe), 127.7
(d, JPC ) 49, C1-ArSO3), 121.0 (d, JPC ) 11, C4-ArOMe), 116.9
(d, JPC ) 57, C1-ArOMe), 112.1 (d, JPC ) 5, C3-ArOMe), 55.9 (s,
ArOMe), 21.5 (s, Me-ArSO3), 3.6 (s, Pd-Me). 31P{1H} NMR
(CD2Cl2): δ 22.2 (s). Anal. Calcd for C26H27N2O5PPdS: C, 50.62;
H, 4.41; N, 4.54. Found: C, 50.31; H, 4.46; N, 4.53.35
1
C29H32NO3PPdS(0.12CH2Cl2) (CH2Cl2 content determined by H
NMR): C, 56.75; H, 5.57; N, 2.20. Found: C, 56.77; H, 5.13; N,
2.13.
[PO-OMe]Pd(Me)(PPh3) (7a). A solution of (TMEDA)PdMe2
(0.129 g, 0.511 mmol) and PPh3 (0.134 g, 0.511 mmol) in CH2Cl2
(5 mL) was cooled to -78 °C, and a solution of [PO-OMe]H (0.213
g, 0.511 mmol) in CH2Cl2 (10 mL) was added dropwise while the
mixture was stirred. The mixture was allowed to warm to room
temperature and was stirred for 2 h. The solvent was removed under
vacuum to give an off-white solid. The solid was recrystallized
from a mixture of CH2Cl2 (8 mL) and hexanes (2 mL) at -20 °C.
Yield: 0.160 g (39%). Mp: 174.3 (dec). 1H NMR (CD2Cl2): δ 7.90
(dd, JHH ) 8, JPH ) 6, 1H, H3-ArSO3), 7.68 (m, 6H, PPh3/H6-
ArOMe), 7.44 (m, 13H, PPh3/H4-ArOMe), 7.28 (dd, JHH ) 8, JPH
) 1, 1H, H4-ArSO3), 7.06 (dd, JPH ) 9, JPH ) 2, 1H, H6-ArSO3),
7.00 (t, JHH ) 8, 2H, H5-ArOMe), 6.96 (dd, JHH ) 88, JPH ) 5,
2H, H3-ArOMe), 3.67 (s, 6H, ArOMe), 2.24 (s, 3H, Me-ArSO3),
-0.12 (t, JPH ) 6, 3H, Pd-Me). 13C{1H} NMR (CD2Cl2): δ 161.3
[PO-OMe]Pd(Me)(py) (6a). A solution of (TMEDA)PdMe2
(7.37 g, 29.2 mmol) in CH2Cl2 (130 mL) was prepared, and [PO-
OMe]H (12.2 g, 29.2 mmol) was added. The mixture was stirred
(35) The reaction of 5a with B(C6F5)3 does not result in pyridazine
abstraction, but rather proceeds by methide abstraction to yield
[MeB(C6F5)3]-, which was identified by NMR and ESI-MS, and unidentified
Pd products.